Archive | April, 2011

Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas–possible role of Cannabis inhalation.

Childs Nerv Syst. 2011 Apr;27(4):671-9. doi: 10.1007/s00381-011-1410-4. Epub 2011 Feb 20. Foroughi M1, Hendson G, Sargent MA, Steinbok P. Author information Abstract INTRODUCTION: Spontaneous regression of pilocytic astrocytoma after incomplete resection is well recognized, especially for cerebellar and optic pathway tumors, and tumors associated with Neurofibromatosis type-1 (NF1). The purpose of this report is to document spontaneous regression of […]

Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life

PLoS One. 2011; 6(4): e18440.  Published online Apr 21, 2011. doi:  10.1371/journal.pone.0018440 PMCID: PMC3080871 Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life Jimena Fiz,1,2 Marta Durán,3 Dolors Capellà,2,3 Jordi Carbonell,4 and  Magí Farré1,2,* Antonio Verdejo García, Editor Author information ► Article notes ► Copyright and License information ► This article has been cited by other articles in PMC. Go to: Abstract Background The aim […]

Cannabinoids: potential targets for bladder dysfunction.

2011;(202):425-51. doi: 10.1007/978-3-642-16499-6_20. Cannabinoids: potential targets for bladder dysfunction. Ruggieri MR Sr. Author information  Abstract Cannabinoids are the active chemical components of Cannabis sativa (marijuana). The medical use of cannabis goes back over 5,000 years. Cannabinoids produce a very wide array of central and peripheral effects, some of which may have beneficial clinical applications. The discovery of cannabinoid receptors […]

Supply and demand for endocannabinoids

Journal List > HHS Author Manuscripts > PMC3106144 Trends Neurosci. Author manuscript; available in PMC 2012 Jun 1. Published in final edited form as: Trends Neurosci. 2011 Jun; 34(6): 304–315.  Published online 2011 Apr 18. doi:  10.1016/j.tins.2011.03.003 PMCID: PMC3106144 NIHMSID: NIHMS290525 Bradley E. Alger1,2,3 and  Jimok Kim1,4,6 Author information ► Copyright and License information ► The publisher’s final edited version of this article is available at Trends Neurosci […]

Molecular reorganization of endocannabinoid signalling in Alzheimer’s disease

Brain. Apr 2011; 134(4): 1041–1060. Published online Mar 31, 2011. doi:  10.1093/brain/awr046 PMCID: PMC3069704 Molecular reorganization of endocannabinoid signalling in Alzheimer’s disease Jan Mulder,1,* Misha Zilberter,2,† Susana J. Pasquaré,3,4,† Alán Alpár,1,† Gunnar Schulte,5 Samira G. Ferreira,6 Attila Köfalvi,6 Ana M. Martín-Moreno,3 Erik Keimpema,1 Heikki Tanila,7 Masahiko Watanabe,8 Ken Mackie,9 Tibor Hortobágyi,10Maria L. de Ceballos,3 and Tibor Harkany1,2 Author information ► Article notes ► Copyright and License information ► This article has been cited by other articles in PMC. Go to: Abstract […]

A drug discovery case history of ‘delta-9-tetrahydrocannabinol, cannabidiol’.

2011 Apr;6(4):437-52. doi: 10.1517/17460441.2011.560935. Epub 2011 Mar 3. A drug discovery case history of ‘delta-9-tetrahydrocannabinol, cannabidiol’. Tanasescu R1, Rog D, Constantinescu CS. Author information  Abstract INTRODUCTION: Although the Cannabis sativa herb has been known for its therapeutic benefit for centuries, the interest in the clinical potential of cannabinoid-based drugs escalated after the discovery of the endocannabinoid system. The understanding […]

Is there a legitimate role for the therapeutic use of cannabinoids for symptom management in chronic kidney disease?

 2011 Apr;41(4):768-78. doi: 10.1016/j.jpainsymman.2010.06.016. Epub 2011 Jan 26. Is there a legitimate role for the therapeutic use of cannabinoids for symptom management in chronic kidney disease? Davison SN1, Davison JS. Author information Abstract Chronic pain is a common and debilitating symptom experienced in the context of numerous other physical and emotional symptoms by many patients with chronic kidney […]